While the exact molecular mechanism behind apoA1’s anti-tumor effect is currently unknown, given the similarities between the results in the cancer and inflammation settings, it is likely that apoA1’s ability to modulate membrane lipid raft cholesterol content influences signalling pathways regulating MDSC recruitment to tumors. This evidence concerns the gene APOA1 and cancer.